Horizon Discovery - CHOSOURCE™ expression platform
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

Novel Repotrectinib Therapeutic Option Discovered for Advanced Solid Tumors

Turning Point Therapeutics, Inc discovered novel repotrectinib, a leading drug candidate for the treatment of patients with advanced solid tumors having an NTRK gene fusion. Repotrectinib is a therapeutic option for patients who have shown progress with 1 or 2 prior TRK TKIs after treatment, with or without prior chemotherapy...

SKYTROFA® (Lonapegsomatropin-tcgd), The First Therapy Discovered for Pediatric Growth Hormone Deficiency

Acendis Pharma discovered SKYTROFA (lonapegsomatropin-tcgd) for the treatment of pediatric growth hormone deficiency. It is the only once-weekly treatment applicable for patients with one year of age and older weighing at least 11.5kg having lack of growth due to insufficient secretion of endogenous...

New Simoa® phospho-Tau 181 (pTau-181) Blood Test Discovered for Alzheimer’s Disease

Quanterix Corporation discovers new Blood-Based pTau-181 Assay for Alzheimer’s Disease. The Simoa® phospho-Tau 181 (pTau-181) blood test will be used for diagnostic evaluation of Alzheimer’s Disease (AD). With the use of HD-X immunoassay system, the pTau-181 concentration in human serum...

Genentech Developed Breakthrough Therapy Gantenerumab for Alzheimer’s Disease

Genentech developed a breakthrough therapy for the treatment of patients living with early Alzheimer's disease (AD). This will be the first medicine to treat Alzheimer’s disease at-home administration. Gantenerumab is the first investigational IgG1 antibody designed with late-stage trials for the treatment of AD...

Novel Novilase® Interstitial Laser System Developed for Breast Cancer

Novian Health Inc. developed Novilase® Interstitial Laser System for the treatment of malignant breast tumors for adult women who undergo breast conserving procedure. The laser therapy helps patients by keeping away from trauma and works as an alternative for breast cancer surgery....

Jardiance® Novel Therapy Developed for the Treatment of Patients with Heart Failure

Eli Lilly and Company in combination with Boehringer Ingelheim has developed Jardiance®, a novel therapy to treat patients with heart failure with preserved ejection fraction (HFpEF). Jardiance is used to lower the blood sugar levels along with diet and exercise in adults with type 2 diabetes, lessens the risk of cardiovascular...

Amdizalisib (HMPL-689) Discovered for the Treatment of Relapsed or Refractory Follicular Lymphoma

Hutchmed Limited discovered novel therapy amdizalisib (HMPL-689), for the treatment of relapsed or refractory follicular lymphoma (“FL”). Amdizalisib is an inhibitor for PI3Kδ (phosphoinositide 3-kinase delta),a lipid kinase which helps in controlling the activation of several important signaling proteins...

Novel Phoenix® Therapy Developed to Treat PTSD

Evren Technologies developed Phoenix®, a novel therapy for the treatment of Post-traumatic Stress Disorder (PTSD). The Phoenix® is an earbud device which delivers a light electrical tingle to activate vagus nerve consisting of a calming effect on the body and also helps in reducing the symptoms of PTSD....

Genentech Developed Breakthrough Therapy Venclexta for Myelodysplastic Syndromes

Genentech developed Venclexta in combination with Azacitidine for the treatment of patients with Myelodysplastic Syndromes. Venclexta in combination with Azacitidine has the ability to treat adult patients who have formerly untreated with intermediate, high- and very high-risk myelodysplastic...

Novel Therapy, Toripalimab, Discovered for the Treatment of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma in combination with Coherus discovered Toripalimab, novel therapy for the treatment of recurrent or metastatic nasopharyngeal carcinoma. Toripalimab, is an anti-PD-1 monoclonal antibodyhaving the ability to block PD-1interactions with its ligands, PD-L1 and PD-L2, and for enhanced receptor internalization (endocytosis function)....

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations Eppendorf SE || LAB Channel Catalent  Asia-Pacific Clinical Supply Solutions SGS - Health Science Horizon - CHOSOURCE advances biotherapeutic production MasterControl - The Never-Normal Future of Manufacturing Medical Fair Thailand 2022 Meco - 90 years